/
/
June 4: The “Myelennial” Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes
June 4: The “Myelennial” Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes image
June 4: The “Myelennial” Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes
Posted May 26, 2022

The HealthTree Foundation for Multiple Myeloma is proud to host a PEERView session at the upcoming ASCO conference with the topic The "Myelennial" Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes. The session will feature myeloma experts Nina Shah, MD, Shaji Kumar, MD and Sagar Lonial, MD.

Register Live or Virtual

Date/Time

  • Saturday, June 4
  • 7:00 - 8:30 pm Central

Key Reasons to Attend

  • Explore recent changes in therapy selection for newly diagnosed MM, including antibody and triplet therapy options, and guideline recommendations for upfront treatment of ASCT-ineligible and -eligible disease
  • Hear the evidence that supports CD38 antibodies, XPO1 inhibitors, and BCMA-targeting options in RRMM
  • Understand how to manage the unique AEs associated with BCMA ADCs, CAR-T therapy, and bispecific agents, such as keratopathy/ocular toxicity, CRS, ICANS, and peripheral neuropathy

This activity has been developed in partnership with HealthTree Foundation for Multiple Myeloma.

Meet Your Presenters

Chair & Presenter
Nina Shah, MD
UCSF Helen Diller Family Comprehensive Cancer Center
The University of California, San Francisco
San Francisco, California

Presenter
Shaji K. Kumar, MD
Mayo Clinic
Rochester, Minnesota

Presenter
Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

The Live meeting will be Hyatt Regency Chicago, Grand Ballroom AB, Ballroom Level (East Tower), 151 East Wacker Drive, Chicago, Illinois 60601

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811